Steve E. Krognes, Director: Denali Therapeutics DNLI Sell · Filed 23/08/23

Trade details

Type: Insider sale
Amount: $32,069.4
Shares · price: 1,419 sh · $22.60 a share
Held after: 145,799 sh
Stock: Denali Therapeutics DNLI
Person: Steve E. KrognesDirector
Trade date: 23/08/21
Filed: 23/08/23
Days to filing: 2 days

Sold 1.0% of holdings

Share of holding sold: 1.0%

Denali Therapeutics trades, last 26 weeks

What else happened in Denali Therapeutics around then

Filed or reported within 30 days of the trade day · 23/07/22~23/09/20

Steve E. Krognes's recent trades

Steve E. KrognesDirector
Planned saleGuardant Health
Planned sale
Guardant Health
GH
$1.2M
6,674 sh
$1.2M
Filed 09/16
Traded 09/16
Steve E. KrognesDirector
SellGuardant Health
Sell
Guardant Health
GH
$1.2M
9,294 sh
$1.2M
Filed 06/05
Traded 06/04
Steve E. KrognesDirector
Planned saleGuardant Health
Planned sale
Guardant Health
GH
$1.2M
9,294 sh
$1.2M
Filed 06/04
Traded 06/04
Steve E. KrognesDirector
SellDenali Therapeutics
Sell
Denali Therapeutics
DNLI
$69.5K
3,339 sh
$69.5K
Filed 25/01/08
Traded 25/01/07
Steve E. KrognesDirector
Planned saleDenali Therapeutics
Planned sale
Denali Therapeutics
DNLI
$69.5K
3,339 sh
$69.5K
Filed 25/01/07
Traded 25/01/07